Castro, Victor M. http://orcid.org/0000-0001-7390-6354
Rosand, Jonathan
Giacino, Joseph T.
McCoy, Thomas H. http://orcid.org/0000-0002-5624-0439
Perlis, Roy H. http://orcid.org/0000-0002-5862-6757
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH120227, R01MH116270)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 7 September 2021
Revised: 18 May 2022
Accepted: 23 May 2022
First Online: 15 June 2022
Competing interests
: The authors report no conflicts of interest. They have the following financial disclosures: THM receives research funding from the Brain and Behavior Research Foundation, Telefonica Alfa, National Institute of Mental Health, National Institute of Nursing Research and National Library of Medicine. RHP holds equity in Psy Therapeutics and Outermost Therapeutics; serves on the scientific advisory boards of Genomind and Takeda; and consults to RID Ventures. RHP receives research funding from NIMH, NHLBI, NHGRI, and Telefonica Alfa. JR consults for Boehringer Ingelheim and receives research support from NIH and American Heart Association. The other authors have no disclosures to report.
Free to read: This content has been made available to all.